Mirum Pharmaceuticals, Inc. MIRM Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermInvestments.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s equity method investments?
- Mirum Pharmaceuticals, Inc. (MIRM) reported equity method investments of $34.35M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s equity method investments changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s equity method investments increased by 64.3% year-over-year, from $20.91M to $34.35M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.